Question: What was the primary goal of the 2021 collaboration between Regeneron and the U.S. government?
Options:
Correct Answer: Creating monoclonal antibodies
Solution:
The collaboration aimed at creating monoclonal antibodies to treat COVID-19, enhancing the therapeutic options available during the pandemic.